Plasma metabolomics in EGC patients during PD-L1 based immunotherapy

ABSTRACT: The PUCH Center's cohort of EGC (gastroesophagus cancer) patients undergoing immunotherapy aims to explore the corresponding plasma metabolomic changes associated with alterations in body composition during immunotherapy.

ORGANISM(S): Homo sapiens (human)

SUBMITTER:  

PROVIDER: S-BSST1712 | biostudies-other |

REPOSITORIES: biostudies-other